Try our beta test site
37 studies found for:    Open Studies | "Dwarfism"
Show Display Options
Rank Status Study
1 Recruiting Short Stature Related Distress
Conditions: Idiopathic Short Stature;   Self Image
Interventions: Drug: GH treatment (Genotropin);   Drug: 1 year treatment with placebo followed by optional 3 years of GH treatment
2 Recruiting Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
Condition: Dwarfism, Pituitary
Intervention: Biological: PEG-somatropin
3 Not yet recruiting Fitness Level in Short Stature Children and After Growth Hormone Treatment
Condition: Fitness
Intervention: Other: change in fitness level
4 Recruiting Effect of Anesthesia on Quality of Recovery in Patients Undergoing Cosmetic Lower Limb Lengthening - A Randomized Controlled Trial
Condition: Short Stature
Interventions: Drug: propofol and remifentanil;   Drug: desflurane and remifentanil
5 Recruiting Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
Condition: Short Stature
Interventions: Drug: Letrozole;   Drug: Anastrozole
6 Recruiting Growth Hormone Secretion Following the Anaerobic Exercise
Condition: Short Stature
Intervention: Other: Anaerobic Test
7 Recruiting Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
Conditions: Dwarfism;   Osteogenesis Imperfecta
Intervention:
8 Recruiting A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
Condition: Idiopathic Short Stature
Interventions: Drug: somatropin;   Drug: triptorelin
9 Recruiting Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys
Conditions: Growth Problem;   Low Weight;   Short Stature
Interventions: Dietary Supplement: Nutritional supplementation standardized formula;   Dietary Supplement: Placebo comparator
10 Recruiting Genetic Causes of Growth Disorders
Conditions: Short Stature;   Growth Disorder
Intervention:
11 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo
12 Recruiting The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents
Conditions: Growth Hormone Deficiency;   Attention Deficit Disorder;   Idiopathic Short Stature
Intervention: Other: Questionnaires
13 Recruiting Versartis Long-Term Safety Study of Somavaratan
Condition: Pediatric Growth Hormone Deficiency
Intervention: Drug: somavaratan
14 Recruiting A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Interventions: Drug: somapacitan;   Drug: Norditropin
15 Not yet recruiting Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy
Conditions: IGHD - Isolated Growth Hormone Deficiency;   Growth Retardation
Interventions: Dietary Supplement: Nutritional supplementation standardized formula;   Dietary Supplement: Placebo
16 Recruiting Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Biological: Jintropin AQ
17 Recruiting Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
18 Recruiting Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: PEG-somatropin
19 Recruiting Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
Condition: Adult Growth Hormone Deficiency (AGHD)
Intervention: Drug: somavaratan
20 Recruiting Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: Norditropin® FlexPro® pen

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.